Search

Your search keyword '"Fiard, Gaelle"' showing total 301 results

Search Constraints

Start Over You searched for: Author "Fiard, Gaelle" Remove constraint Author: "Fiard, Gaelle"
301 results on '"Fiard, Gaelle"'

Search Results

1. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients

3. External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification

4. The impact of prostate volume estimation on the risk‐adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score

11. Performance of a Region of Interest–based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database—CAD-FIRST Study

13. Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)

14. Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach

15. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy

16. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging–Targeted and Systematic Biopsies: A European Multicenter Study

17. Magnetic Resonance Imaging Follow-up of Targeted Biopsy–negative Prostate Lesions

18. Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification

19. Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?

20. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy

21. Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study

22. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

23. PD50-12 THE ADDED VALUE OF SIDE SPECIFIC SYSTEMATIC BIOPSY IN PATIENTS DIAGNOSED BY MAGNETIC RESONANCE IMAGING-TARGETED PROSTATE BIOPSY

26. Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?

27. Impact of Hospital Volume on the Outcomes of Renal Trauma Management

28. Factors Predictive of Selective Angioembolization Failure for Moderate- to High-grade Renal Trauma: A French Multi-institutional Study

29. From Reporting to Improving: How Root Cause Analysis in Teams Shape Patient Safety Culture.

32. Transperineal or Transrectal Magnetic Resonance Imaging–targeted Biopsy for Prostate Cancer Detection

33. The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging–targeted Prostate Biopsy

36. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic

38. Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group

40. Initial validation of a virtual-reality learning environment for prostate biopsies: realism matters!

41. Using CamiTK for rapid prototyping of interactive Computer Assisted Medical Intervention applications

42. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project)

43. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

44. Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions

45. Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

47. Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

48. Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining‐targeted biopsy

50. Stopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial

Catalog

Books, media, physical & digital resources